Dal-Outcomes II (Completed)
A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
- Medicine
- dalcetrapib
- Population
- ASCVD
- Phase
- III
- Starting year
- 2011
- More information
- ClinicalTrials.gov